| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 04/28/2011 | WO2011049520A1 Adamantyl iminocarbonyl-substituted pyrimidines as inhibitors of 1 1 betahsd1 |
| 04/28/2011 | WO2011047432A1 Fused ring analogues of anti-fibrotic agents |
| 04/28/2011 | WO2011023791A3 Method for producing organoaluminium compounds and use thereof |
| 04/28/2011 | WO2011021216A3 Improved process for preparing 4-(l, l-dimethylethyl)-n-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2' -bipyrimid in]-4-yl]benzene sulfonamide |
| 04/28/2011 | WO2011017334A3 Mesoionic pesticides |
| 04/28/2011 | US20110098472 Processes for the preparation of uracil derivatives |
| 04/28/2011 | US20110098313 Positive allosteric modulators (pam) |
| 04/28/2011 | US20110098305 Arylsulfonamide compounds, compositions and methods of use |
| 04/28/2011 | US20110098301 Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders |
| 04/28/2011 | US20110098288 Sulfonamides as zap-70 inhibitors |
| 04/28/2011 | US20110098285 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/28/2011 | US20110098280 2,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 04/27/2011 | EP2314593A1 Platelet ADP receptor inhibitors |
| 04/27/2011 | EP2314576A1 Phenyl derivatives as PPAR agonists |
| 04/27/2011 | EP2314568A2 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 04/27/2011 | EP2312951A1 Bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 04/27/2011 | EP2102199B1 Antibacterial polycyclic urea compounds |
| 04/27/2011 | EP1689723B1 Reference standard for characterization of rosuvastatin |
| 04/27/2011 | EP1622879B1 Pyrimidine compounds and pests controlling compositions containing the same |
| 04/27/2011 | EP1521746B1 Quinazolinone modulators of nuclear receptors |
| 04/27/2011 | CN1810802B 3-substituted-4-pyrimidone derivatives |
| 04/27/2011 | CN102030722A Process for the preparation of 4- (3'-chloro-4'-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline |
| 04/27/2011 | CN102030716A Method for preparing gefitinib |
| 04/27/2011 | CN102030715A Method for synthetizing cytosine |
| 04/27/2011 | CN102030653A Polymerizable compound |
| 04/27/2011 | CN101638391B 2-[(substituted aminobenzene)carbonylmethylthio]-6-(2,6-dichlorobenzyl)-3H-pyrimidyl-4-ketone derivative and preparation method and application thereof |
| 04/27/2011 | CN101602732B Derivative of acyl thiourea pyridine, method for preparing same and application thereof |
| 04/27/2011 | CN101165057B Nbeta-substituted phenyluracil compounds for removing glass |
| 04/27/2011 | CN101092417B Folacin analogue, and salt of folacin analogue in use for medical treatment |
| 04/27/2011 | CN101033224B Novel pyrimidines small molecular compound, its preparation method and use |
| 04/26/2011 | US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/26/2011 | US7932387 Crystalline forms of rosuvastatin calcium salt |
| 04/26/2011 | US7932385 Paliperidone ketone |
| 04/26/2011 | US7932376 Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation |
| 04/26/2011 | US7932260 5-methyl-3-phenyl-2-[1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one; 3-(4-fluoro-phenyl)-5-methyl-2-[1-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ethyl]-3H-quinazolin-4-one; bone-resorption disorder or a cancer of a hematopoietic origin; disorders in which PI3K plays a role in leukocyte function |
| 04/26/2011 | US7932240 Phosphadiazine HCV polymerase inhibitors IV |
| 04/26/2011 | CA2634676C Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein cetp |
| 04/26/2011 | CA2583742C 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists |
| 04/26/2011 | CA2500952C Neurologically-active compounds |
| 04/26/2011 | CA2479133C 2-4-diaminopyrimidine derivatives |
| 04/26/2011 | CA2477657C Cathepsin cysteine protease inhibitors |
| 04/26/2011 | CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 04/26/2011 | CA2416955C Process and intermediates for preparing retroviral protease inhibitors |
| 04/26/2011 | CA2376064C Factor viia inhibitors |
| 04/26/2011 | CA2345103C (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 04/21/2011 | WO2011047323A2 Antimicrobial compounds and methods of making and using the same |
| 04/21/2011 | WO2011046970A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | WO2011045224A1 1- (pyrid-3-yl) -pyrazole and 1- (pyrimid-5-yl) -pyrazole as pesticide |
| 04/21/2011 | WO2011017347A3 Mesoionic pesticides |
| 04/21/2011 | US20110092701 Compounds for electronic devices |
| 04/21/2011 | US20110092526 Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826 |
| 04/21/2011 | US20110092489 3-Aryl-Substituted Quinazolones, and Uses Thereof |
| 04/21/2011 | US20110090450 Four-ring liquid crystal compound having lateral fluorine, liquid crystal composition and liquid crystal display device |
| 04/21/2011 | CA2777762A1 Amino - pyrimidine compounds as inhibitors of tbk1 and/or ikk epsilon |
| 04/21/2011 | CA2777741A1 Antimicrobial compounds and methods of making and using the same |
| 04/20/2011 | EP2311850A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/20/2011 | EP2311825A1 Pyrimidineamines as angiogenesis modulators |
| 04/20/2011 | EP2311824A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 04/20/2011 | EP2311815A1 2-(2-Fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidine carboxylates and their use as herbicides |
| 04/20/2011 | EP2311807A1 Compounds and composition as protein kinase inhibitors |
| 04/20/2011 | EP2311801A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2011 | EP2310376A1 High flow supramolecular compounds |
| 04/20/2011 | EP2309856A1 Pharmaceutical compounds as cytotoxic agents and the use thereof |
| 04/20/2011 | EP1877384B1 Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids |
| 04/20/2011 | EP1603887B1 Hiv replication inhibiting indane substituted pyrimidines |
| 04/20/2011 | CN1854130B Chinazoline derivative, its production, medicinal composition and use |
| 04/20/2011 | CN102026985A Quinazoline derivatives as RAF kinase modulators and methods of use thereof |
| 04/20/2011 | CN102026984A Synthesis of dihydrothieno[3,2-d]pyrimidine diols and similar pyrimidine diols |
| 04/20/2011 | CN102026970A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 04/20/2011 | CN102020653A New application of amino perhydrogenated quinazoline compound and derivative preparation thereof for improving drug effects of anticancer drugs |
| 04/20/2011 | CN102020613A Amino sulfonylureas compound with herbicidal activity and the application thereof |
| 04/20/2011 | CN102020612A Method for synthesizing benzoxycarbonyl basic group |
| 04/20/2011 | CN102020573A Photoelectric conversion material, film containing the material, photoelectric conversion device, production method thereof, photosensor, imaging device and their use methods |
| 04/20/2011 | CN101245051B 2,4-di-substituted amido-6-substituted-[1,3,5]triazine or miazines compound, preparation method, pharmaceutical combination and use of the same |
| 04/20/2011 | CN101219997B Synthesis of 2-chlorine-5- amido pyrimidine |
| 04/20/2011 | CN101203496B Process for preparing pure amorphous rosuvastatin calcium |
| 04/20/2011 | CN101171237B Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids |
| 04/20/2011 | CN101065100B Thienopyrimidines as cooling agents |
| 04/20/2011 | CN101010299B Six-membered heterocycles useful as serine protease inhibitors |
| 04/19/2011 | US7928110 Pyrimidine compound and pests controlling composition containing the same |
| 04/19/2011 | US7928109 focal adhesion kinase inhibitor, i.e. FAK inhibitor; tyrosine kinase inhibitors; cancer, osteoporosis; e.g. N-methyl-4-({4-[({3-[methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride |
| 04/19/2011 | US7928107 Quinazolines useful as modulators of ion channels |
| 04/19/2011 | US7928031 Catalyst comprising indium salt and organic ionic liquid and process for friedel-crafts reactions |
| 04/19/2011 | CA2625563C Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist |
| 04/19/2011 | CA2539476C Quinazoline potassium channel inhibitors |
| 04/19/2011 | CA2453505C Preparation of aminopyrimidine compounds |
| 04/19/2011 | CA2393802C 3-aminoquinazolin-2,4-dione antibacterial agents |
| 04/14/2011 | WO2011042145A1 Wnt pathway antagonists |
| 04/14/2011 | WO2010142766A3 Pyrimidine derivatives as zap-70 inhibitors |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | US20110086822 Substituted Tetracycline Compounds |
| 04/14/2011 | US20110086759 Chemical compounds |
| 04/13/2011 | EP2308926A1 Composition comprising phosphorescence emitting compound, and light emitting element using the composition |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
| 04/13/2011 | EP2308854A1 2,3,6-trisubstituted-4-pyrimidone derivatives |
| 04/13/2011 | EP2308853A1 Process for the preparation of aminopyrimidines |
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |